What preoperative optimization is recommended for a wheelchair‑bound patient in whom exercise tolerance (metabolic equivalents) cannot be assessed?

Preoperative Optimization for Wheelchair-Bound Patients with Unknown Functional Capacity

For wheelchair-bound patients in whom metabolic equivalents (METs) cannot be assessed through exercise testing, proceed with pharmacological stress testing (dobutamine stress echocardiography or myocardial perfusion imaging) if the results will impact decision-making or perioperative care, combined with guideline-directed medical therapy optimization. 1, 2, 1

Risk Stratification Approach

The 2014 ACC/AHA guidelines provide a clear algorithmic pathway for patients with unknown functional capacity:

Step 1: Determine surgical risk

• Low-risk surgery: Proceed without further testing
• Intermediate or elevated-risk surgery: Continue evaluation 1, 2

Step 2: Assess clinical risk factors (Revised Cardiac Risk Index):

• History of ischemic heart disease
• History of compensated or prior heart failure
• History of cerebrovascular disease
• Diabetes mellitus requiring insulin
• Chronic kidney disease (creatinine >2 mg/dL) 1, 2

Step 3: For patients with ≥1 clinical risk factor undergoing intermediate/elevated-risk surgery:

Since exercise capacity cannot be assessed in wheelchair-bound patients, pharmacological stress testing is reasonable if it will change management (Class IIa, Level of Evidence B). 1

Specific Testing Recommendations

Pharmacological stress testing options:

• Dobutamine stress echocardiography (DSE)
• Myocardial perfusion imaging (MPI)

Both are equally acceptable for patients at elevated risk with poor or unknown functional capacity 1

Important caveat: Only perform stress testing if results will impact:

• Decision to proceed with original surgery
• Willingness to undergo coronary revascularization
• Perioperative care strategies 1, 2

If testing will NOT change management, proceed directly to surgery with guideline-directed medical therapy 1, 2

Medical Optimization

Cardiovascular medications:

1. Beta-blockers (Class I recommendation):

   • MUST continue if already prescribed for angina, symptomatic arrhythmias, hypertension, or other ACC/AHA Class I indications 3
   • For vascular surgery with coronary disease or ≥1 clinical risk factor: reasonable to initiate (Class IIa) 3

2. Statins (Class IIa recommendation):

   • Reasonable for patients undergoing vascular surgery regardless of clinical risk factors 3
   • May be considered for intermediate-risk procedures with ≥1 clinical risk factor (Class IIb) 3

Preoperative evaluation components:

• 12-lead ECG: Reasonable for patients with known coronary disease or significant structural heart disease, except for low-risk surgery (Class IIa) 1, 2

• Left ventricular function assessment: Reasonable for patients with dyspnea of unknown origin or heart failure with worsening symptoms (Class IIa) 1

Additional Optimization Strategies

Medical comorbidities to address:

1. Diabetes control: Target HbA1c ≤7.5% 4
2. Anemia correction: Hemoglobin >12.0 g/dL (women) or >13.0 g/dL (men) 4
3. Nutritional status: Serum albumin ≥3.5 g/dL 4
4. Smoking cessation: 4 weeks minimum before surgery 5, 4
5. Alcohol cessation: 4 weeks for alcohol abusers 5

Metabolic considerations:

Recent evidence suggests metabolic flexibility—the ability to switch between fuel sources—may predict postoperative outcomes 6, 7. While wheelchair-bound patients cannot undergo traditional exercise testing, optimizing metabolic health through nutritional interventions and medical management may improve perioperative resilience.

Critical Decision Point

The key question: Will stress testing results change your management?

• YES → Perform pharmacological stress testing

  • If abnormal: Consider coronary angiography and revascularization based on extent of abnormality
  • If normal: Proceed to surgery with guideline-directed medical therapy 1, 2

• NO → Proceed directly to surgery with guideline-directed medical therapy or consider alternative strategies (radiation therapy for cancer, palliation) 1, 2

Common Pitfalls to Avoid

1. Do not perform routine coronary revascularization solely to reduce perioperative cardiac events (Class III: No Benefit) 1

2. Do not order routine preoperative coronary angiography (Class III: No Benefit) 1

3. Do not stop beta-blockers in patients already taking them for established indications 3

4. Do not delay surgery for extensive testing if results won't change management—this increases overall morbidity without benefit 1, 2

The wheelchair-bound status itself does not preclude surgery but necessitates alternative assessment methods focused on pharmacological stress testing when functional capacity assessment is impossible and clinical risk factors are present.